These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 18165769

  • 21. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.
    Transplantation; 2009 Sep 27; 88(6):826-34. PubMed ID: 19920783
    [Abstract] [Full Text] [Related]

  • 22. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
    Cywinski JB, Mascha E, Miller C, Eghtesad B, Nakagawa S, Vincent JP, Pesa N, Na J, Fung JJ, Parker BM.
    Liver Transpl; 2008 Jan 27; 14(1):59-65. PubMed ID: 18161840
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Jan 27; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Excellent liver transplant survival rates under the MELD/PELD system.
    Freeman RB, Harper A, Edwards EB.
    Transplant Proc; 2005 Mar 27; 37(2):585-8. PubMed ID: 15848465
    [Abstract] [Full Text] [Related]

  • 31. Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers.
    Vitale A, D'Amico F, Brolese A, Zanus G, Boccagni P, Neri D, Gringeri E, Valmasoni M, Ciarleglio FA, Carraro A, Pauletto A, Bonsignore P, Bassi D, Polacco M, D'Amico DF, Cillo U.
    Transplant Proc; 2007 Mar 27; 39(6):1907-9. PubMed ID: 17692650
    [Abstract] [Full Text] [Related]

  • 32. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F, Coria SA, Boni R, Pereira LA.
    Transplant Proc; 2009 Mar 27; 41(1):226-8. PubMed ID: 19249520
    [Abstract] [Full Text] [Related]

  • 33. Should liver transplantation in patients with model for end-stage liver disease scores <or= 14 be avoided? A decision analysis approach.
    Perkins JD, Halldorson JB, Bakthavatsalam R, Fix OK, Carithers RL, Reyes JD.
    Liver Transpl; 2009 Feb 27; 15(2):242-54. PubMed ID: 19177441
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cost prediction in liver transplantation using pretransplant donor and recipient characteristics.
    Earl TM, Cooil B, Rubin JE, Chari RS.
    Transplantation; 2008 Jul 27; 86(2):238-44. PubMed ID: 18645485
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May 27; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.